Skip to main content
Autobound logo
Caris Life Sciences10-K: Digital transformation

Planning to launch new blood-based detection solution, Caris Detect, in 2026

Read at SEC EDGAR

What happened

The upcoming launch of the Caris Detect assay is a major strategic initiative that will require significant investment in go-to-market activities, sales enablement, regulatory compliance, and the underlying technology infrastructure to support the new service at scale.

Source

Other signals in this filing (11)

Extracted by Autobound

From the Signal API record
Signal
10-K: Digital transformation

What this signalsFilings often name leadership changes, deals and spending plans.

Period
FY2025
Fiscal year end
12/31
Filed
Mar 3, 2026

More from Caris Life Sciences

Company page →

More 10-K signals at other companies

The full record

From the Signal API record

Details

CIK
2019410
Accession number
0002019410-26-000016
Timeframe
Next year
Filing year
2026
Why it matters
Multi-year tech investment
Signal category
Strategic

Topics and mentions

Technologies

  • WGS
  • AI
  • ML

Extraction

Confidence
High
Relevance
90%
Sentiment
Positive
Detected
Mar 10, 2026
signal_type
sec-10k
signal_subtype
digitalTransformation

Use this data

Get every 10-K signal for Caris Life Sciences and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/1d1cb966-7d80-4280-bfd4-8bdb261fb7aa returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.

{
  "signal_id": "1d1cb966-7d80-4280-bfd4-8bdb261fb7aa",
  "signal_type": "sec-10k",
  "signal_subtype": "digitalTransformation",
  "detected_at": "2026-03-10T06:44:07.681+00:00",
  "company": {
    "name": "Caris Life Sciences",
    "domain": "carislifesciences.com"
  },
  "data": {
    "detail": "The upcoming launch of the Caris Detect assay is a major strategic initiative that will require significant investment in go-to-market activities, sales enablement, regulatory compliance, and the underlying technology infrastructure to support the new service at scale.",
    "metrics": {
      "timeframe": "next_year"
    },
    "summary": "Planning to launch new blood-based detection solution, Caris Detect, in 2026",
    "excerpts": "Our novel blood-based detection solution, Caris Detect, is expected to launch in 2026.",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000016/cai-20251231.htm",
    "filing_date": "2026-03-03",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Multi-year tech investment",
    "signal_category": "strategic",
    "technologies_mentioned": [
      "WGS",
      "AI",
      "ML"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.